Prime Medicine Inc
PRME
Company Profile
Business description
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.
Contact
60 First Street
CambridgeMA02141
USAT: +1 617 564-0013
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2025
Employees
214
Stocks News & Analysis
stocks
Has the most hated company on the ASX 200 bounced back?
Encouraging results indicate a potential turnaround story.
stocks
Amazon earnings: Good results, with AWS still a winner; fear on profitability guidance is overblown
We think Amazon stock looks attractive.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,922.00 | 4.90 | 0.05% |
| CAC 40 | 7,608.73 | 62.57 | 0.83% |
| DAX 40 | 23,747.11 | 321.14 | 1.37% |
| Dow JONES (US) | 43,588.58 | 542.40 | -1.23% |
| FTSE 100 | 9,105.38 | 36.80 | 0.41% |
| HKSE | 24,733.45 | 225.64 | 0.92% |
| NASDAQ | 20,650.13 | 472.31 | -2.24% |
| Nikkei 225 | 40,290.70 | 508.90 | -1.25% |
| NZX 50 Index | 12,684.04 | 45.36 | -0.36% |
| S&P 500 | 6,238.01 | 0.00 | 0.00% |
| S&P/ASX 200 | 8,663.70 | 1.70 | 0.02% |
| SSE Composite Index | 3,583.31 | 23.36 | 0.66% |